20 September 2024 - In this article, we estimate the initial and temporal impacts of generic entry on benchmark drug prices as reimbursed through the PBS of Australia and the degree to which further generic competition affects these prices under the current regulatory framework.

Our results suggest that generic entry into the Australian pharmaceutical market causes significant initial price reductions of approximately 31% and that successive generic entrants also act to further reduce drug prices.

Read Value in Health article